ArticleBritish journal of pharmacology2015

Effects of chronic treatment with the new ultra-long-acting β2 -adrenoceptor agonist indacaterol alone or in combination with the β1 -adrenoceptor blocker metoprolol on cardiac remodelling.

Barbara Rinaldi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.